Brands: Kaletra · Lopinavir + Ritonavir
Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Camber Pharmaceuticals, Inc. | generic | 6 | SUPPLYING |
| AbbVie Inc. | unknown | 4 | SUPPLYING |
| Macleods Pharmaceuticals Limited | generic | 2 | SUPPLYING |
| Laurus Labs Limited | unknown | 2 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Lopinavir and Ritonavir Tablet — reported in shortage by AbbVie Inc.. Therapeutic category: Antiviral.
Lopinavir and Ritonavir Tablet — reported in shortage by AbbVie Inc.. Therapeutic category: Antiviral.
Lopinavir and Ritonavir Oral Solution — reported in shortage by AbbVie Inc.. Therapeutic category: Antiviral.
Lopinavir and Ritonavir Oral Solution — reported in shortage by AbbVie Inc.. Therapeutic category: Antiviral.
